Avricore Health (AVCRF) Income from Continuing Operations (2009 - 2025)
Avricore Health (AVCRF) posted quarterly Income from Continuing Operations of 35788.23 for Q3 2025, down 111.23% YoY from 318731.62 in Q3 2024, and down 12.14% sequentially from 31914.13 in Q2 2025.
Avricore Health (AVCRF) Income from Continuing Operations (2009 - 2025) Analysis & Trends
Avricore Health has disclosed Income from Continuing Operations across 17 years of filings, most recently posting 35788.23 for Q3 2025.
- In Q3 2025, Income from Continuing Operations fell 111.23% year-over-year to 35788.23; the TTM figure through Sep 2025 stood at 492928.28 (down 62.62% YoY), while the FY2025 annual figure was 179230.24, down 86.95% from the prior year.
- Income from Continuing Operations retreated to 35788.23 in Q3 2025, from 31914.13 in the prior quarter.
- Over the last five years, Income from Continuing Operations for AVCRF reached as high as 2438575.49 in Q4 2021 and fell as low as 543686.17 in Q1 2021.
- The 5-year median for Income from Continuing Operations is 163335.11 (2023), against an average of 210010.76.
- Annual changes were most pronounced in 2021 — Income from Continuing Operations slumped 258.3% — and 2023, when it surged 2059.94%.
- A 5-year view of Income from Continuing Operations shows it stood at 2438575.49 in 2021, then sank by 42.43% to 1403790.4 in 2022, then slumped by 73.71% to 369002.74 in 2023, then dropped by 13.62% to 318731.62 in 2024, then plunged by 111.23% to 35788.23 in 2025.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 35788.23, 31914.13, and 241899.01 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -85.11 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 339.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 269.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Avricore Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -35,788.23 |
| Jun 30, 2025 | -31,914.13 |
| Mar 31, 2025 | 241,899.01 |
| Sep 30, 2024 | 318,731.62 |
| Jun 30, 2024 | 271,088.64 |
| Mar 31, 2024 | 359,776.48 |
| Dec 31, 2023 | 369,002.74 |
| Sep 30, 2023 | 195,274.90 |
| Jun 30, 2023 | 170,830.25 |
| Mar 31, 2023 | 155,839.97 |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | -444,623.11 |
| Jun 30, 2022 | -371,857.47 |
| Mar 31, 2022 | 7,215.02 |
| Dec 31, 2021 | 2.44 Mn |
| Sep 30, 2021 | -390,957.42 |
| Jun 30, 2021 | -333,004.33 |
| Mar 31, 2021 | -543,686.17 |
| Dec 31, 2020 | 868,109.51 |
| Sep 30, 2020 | -109,114.60 |